Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 4,047
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC),
Location: New York NY, Boston MA, Columbus OH, Grand Rapids MI,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06784193
Phase 1, Recruiting
Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2
for
Critically Ill, Hyperglycemia
Location: New York NY, Lebanon NH, Winston-Salem NC, Columbus OH,
Sponsor: Intermountain Health Care, Inc.
Sex: All
Age: 0+
Code: NCT00654797
Phase 2, Recruiting
Study on Magnetic Field Therapy to Improve Quality of Sleep and Reduction of Chronic Spine Pain
for
Back Pain, Neck Pain,
Location: Briarcliff Manor NY
Sponsor: Weintraub, Michael I., MD, FACP, FAAN
Sex: All
Age: 18 - 70+
Code: NCT00445133
Recruiting
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: New York NY, Hackensack NJ, Boston MA, Baltimore MD,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05372354
Phase 1, Phase 2, Recruiting
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
for
Crohn's Disease
Location: New York NY, Hamden CT, Providence RI, Montreal,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06045754
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Roslyn NY, Stony Brook NY, Camden NJ, Philadelphia PA,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase 3, Recruiting
Phase III Presbyopia Correction Using the VIS Opti-K™ System
for
Presbyopia
Location: Teaneck NJ, Oceanside NY, South Dartmouth MA,
Sponsor: VIS, Inc.
Sex: All
Age: 40+
Code: NCT06487897
Phase 3, Recruiting
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
for
Prostate Cancer
Location: New York NY
Sponsor: Weill Medical College of Cornell University
Sex: Male
Age: 21 - 70+
Code: NCT04402151
Phase 2, Recruiting
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
for
Cholangiocarcinoma, Pancreatic Cancer, Bile Duct Cancer,
Location: New York NY, Boston MA
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT01439698
Recruiting
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
for
B-cell Acute Lymphoblastic Leukemia
Location: New York NY, Philadelphia PA, Boston MA, Buffalo NY,
Sponsor: Cellectis S.A.
Sex: All
Age: 15 - 50
Code: NCT04150497
Phase 1, Phase 2, Recruiting
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
for
Cirrhosis, Cirrhosis, Liver, Cirrhosis Early,
Location: New York NY, Richmond VA, Cleveland OH, Durham NC,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 18 - 70+
Code: NCT05832229
Phase 2, Recruiting
A New Treatment for Zenker's Diverticulum-submucosal Tunneling Endoscopic Septum Division
for
Zenker Diverticulum
Location: Mineola NY
Sponsor: Shanghai Zhongshan Hospital
Sex: All
Age: 18+
Code: NCT03125733
Recruiting
Safety of Oral Anticoagulants Registry
for
Blood Coagulation
Location: Brooklyn NY, Hartford CT, West Reading PA, Cleveland OH,
Sponsor: Hospital Quality Foundation
Sex: All
Age: 18+
Code: NCT02745054
Recruiting
Featured
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
for
Immunoglobulin Light Chain (AL) Amyloidosis
Location: New York NY, Boston MA, Winston-Salem NC, Charlotte NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06158854
Phase 1, Phase 2, Recruiting
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma